All Stories

  1. Optimizing case reports and case series: guidance on how to improve quality

    Article • British Journal of Dermatology, April 2018, Wiley

    Dr Ignacio Garcia-Doval, Joerg Albrecht

  2. When to switch biologics: some answers, but lots of questions too

    Article • British Journal of Dermatology, January 2018, Wiley

    Joerg Albrecht

  3. Development of resistance to Mycobacterium tuberculosis is manageable in hidradenitis suppurativa. Response to ‘Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?’

    Article • British Journal of Dermatology, November 2017, Wiley

    Joerg Albrecht

  4. Clinical presentation of terbinafine-induced severe liver injury and the value of laboratory monitoring: a Critically Appraised Topic

    Article • British Journal of Dermatology, October 2017, Wiley

    Joerg Albrecht

  5. Not every patient needs a triglyceride check, but all can get pancreatitis: a systematic review and clinical characterization of isotretinoin-associated pancreatitis

    Article • British Journal of Dermatology, September 2017, Wiley

    Joerg Albrecht

  6. Switching expensive drugs with frequently diminishing value

    Article • British Journal of Dermatology, August 2017, Wiley

    Joerg Albrecht

  7. Positive about negative: no need for a pink cloud of fluff and justifications

    Article • British Journal of Dermatology, July 2017, Wiley

    Joerg Albrecht

  8. Paternal drug exposure: plenty of confounders, few conclusions

    Article • British Journal of Dermatology, April 2017, Wiley

    Joerg Albrecht

  9. A new option on the horizon for the treatment of psoriasis: it is needed, but not at any price

    Article • British Journal of Dermatology, June 2016, Wiley

    Joerg Albrecht